These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 82809)

  • 1. Lowered erythrocyte-sedimentation rate with sodium valproate.
    Hutchinson RM; Clay CM; Simpson MR; Wood JK
    Lancet; 1978 Dec; 2(8103):1309. PubMed ID: 82809
    [No Abstract]   [Full Text] [Related]  

  • 2. Lowered erythrocyte-sedimentation rate with sodium valproate.
    Nutt JG; Neophytides AN; Lodish JR
    Lancet; 1978 Sep; 2(8090):636. PubMed ID: 80565
    [No Abstract]   [Full Text] [Related]  

  • 3. Neonatal fibrinogen depletion caused by sodium valproate.
    Bavoux F; Fournier-Perhilou AI; Wood C; Francoual C; Boccara JF
    Ann Pharmacother; 1994 Nov; 28(11):1307. PubMed ID: 7849355
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen depletion with sodium valproate.
    Dale BM; Purdie GH; Rischbieth RH
    Lancet; 1978 Jun; 1(8077):1316-7. PubMed ID: 78084
    [No Abstract]   [Full Text] [Related]  

  • 5. Neonatal afibrinogenaemia due to sodium valproate.
    Majer RV; Green PJ
    Lancet; 1987 Sep; 2(8561):740-1. PubMed ID: 2888962
    [No Abstract]   [Full Text] [Related]  

  • 6. [Three cases of hypofibrinogenemia induced by chemotherapy with a combination of synthetic ACTH and valproic acid].
    Tokuda K; Kodani N; Ogino T
    No To Hattatsu; 1994 Jan; 26(1):50-6. PubMed ID: 8280448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood level profile of valproate administration under therapeutic conditions in children].
    Meyer FP; Sauer I; Staemmler U; Walther H
    Padiatr Grenzgeb; 1990; 29(4):325-30. PubMed ID: 2216528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudo valproate-induced hypofibrinogenemia.
    Breningstall GN; Cich JA
    Pediatr Neurol; 1996 May; 14(4):345. PubMed ID: 8962595
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incidence of hypofibrinogenemia under valproate. Could it allow the detection of hepatotoxicity of this drug?].
    Coquerel A; Senant J; Samson M; Sauger F; Samson-Dollfus D; Parain D; Leroy A; Hue G; Borg JY; Matray F
    Presse Med; 1986 Oct; 15(34):1733. PubMed ID: 2947142
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of valproic acid and sodium valproate (author's transl)].
    Sorel L; Rucquoy-Ponsar M; Willems C; Diepart E; Harmant J
    Acta Neurol Belg; 1981; 81(5):283-90. PubMed ID: 6797226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma sodium valproate levels and clinical response in epilepsy.
    Anthony M; Hinterberger H; Lance JW
    Clin Exp Neurol; 1977; 14():208-15. PubMed ID: 358186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of epilepsy. Superiority of a single daily dose of sodium valproate over fractionated doses].
    Giroud M; Dumas M; Escousse A; Dumas R
    Presse Med; 1988 Sep; 17(30):1544. PubMed ID: 2971952
    [No Abstract]   [Full Text] [Related]  

  • 13. [Monotherapy with sodium valproate in generalized primary epilepsy. 2d phase: Study of long-term efficacy and tolerance].
    Feuerstein J; Revol M; Roger J; Sallou C; Truelle JL; Vercelletto P; Weber M
    Sem Hop; 1983 Apr; 59(16):1263-74. PubMed ID: 6191393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Daily fluctuations of plasma diphenylhydantoin in patients treated with diphenylhydantoin and sodium valproate].
    Pisani F; Di Perri R
    Acta Neurol (Napoli); 1981 Feb; 3(1):61-3. PubMed ID: 6787844
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy.
    Wheless JW; Vazquez BR; Kanner AM; Ramsay RE; Morton L; Pellock JM
    Neurology; 2004 Oct; 63(8):1507-8. PubMed ID: 15505177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of sodium valproate in severe epilepsy.
    Richens A; Ahmad S
    Br Med J; 1975 Nov; 4(5991):255-6. PubMed ID: 1104059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium valproate.
    Lancet; 1988 Nov; 2(8622):1229-31. PubMed ID: 2903957
    [No Abstract]   [Full Text] [Related]  

  • 18. Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives.
    Tomson T; Luef G; Sabers A; Pittschieler S; Ohman I
    Neurology; 2006 Oct; 67(7):1297-9. PubMed ID: 17030773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate: dose-plasma level relationships and interdose fluctuations.
    Vajda FJ; Mihaly GW; Miles JL; Morris PM; Bladin PF
    Clin Exp Neurol; 1978; 15():145-53. PubMed ID: 386306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium valproate reassessed.
    Drug Ther Bull; 1981 Nov; 19(24):93-5. PubMed ID: 6793342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.